News on Medial

Neurotechnology startup Mave Health secures $2.1 Mn led by Blume Ventures

EntrackrEntrackr · 2h ago
Neurotechnology startup Mave Health secures $2.1 Mn led by Blume Ventures
Medial

Neurotechnology startup Mave Health secures $2.1 Mn led by Blume Ventures Neurotechnology startup Mave Health has raised $2.1 million (approximately Rs 18 crore) in a seed funding round led by Blume Ventures, with participation from Inuka Capital, Stanford Angels, founders of Groww, Raymond Russell, Aureolis Ventures, Juhi Bhatnagar, and existing investor All In Capital, among others. This follows the company’s $750K pre-seed round raised in November 2023. According to a press release, the fresh capital will be used to launch its wearable headset in the United States and India, as well as to scale manufacturing capabilities. Founded in 2023 by Dhawal Jain, Jai Sharma, and Aman Kumar, Mave Health develops non-invasive wearable headsets designed to improve focus, mood, and stress regulation. The device uses transcranial direct current stimulation (tDCS) to target the prefrontal cortex through 20-minute daily sessions. The lightweight (approximately 100g) headset delivers low-intensity electrical stimulation to brain regions associated with attention and emotional regulation. It can be used during daily routines and lasts up to a month on a single charge with regular usage. Mave’s companion app enables users to log sessions, personalize protocols, and track progress without collecting brain data. Users typically report noticeable improvements within 15 to 20 days, with benefits compounding over time. The device is currently available for pre-order in the US and India, with shipments scheduled to begin in April 2026. The company claims strong early traction, with three limited batches selling out within 36 hours. Its launch video has garnered over a million impressions across social platforms, and the product has attracted interest from global technology leaders and athletes, including UFC fighter Max Griffin. Mave entered the market with over 500 beta users ahead of its public release last month. Based on self-reported data after four weeks of usage, 80% of users reported productivity gains exceeding 60%, 75% reported stress reductions above 50%, and users reported an average mood improvement of 77%.

Related News

Volt14 raises $1.87 Mn in pre-Series A round led by Blume Ventures

EntrackrEntrackr · 10m ago
Volt14 raises $1.87 Mn in pre-Series A round led by Blume Ventures
Medial

Volt14 raises $1.87 Mn in pre-Series A round led by Blume Ventures Battery technology startup Volt14 has secured $1.87 million in its pre-Series A funding round led by Blume Ventures. Beyond Next Ventures, Spectrum Impact. Shashank Pathak 05 May 2025 11:12 IST Follow Us New Update Battery technology startup Volt14 has secured $1.87 million in its pre-Series A funding round led by Blume Ventures. Beyond Next Ventures, Spectrum Impact, Supermorpheus, and returning investor Cocoon Capital have also participated. The total funding raised by the Bengaluru-based startup now stands at $4.02 million. The proceeds will be used to scale up manufacturing and expand its team. Founded in 2019 by Animesh Kumar Jha, Volt14 focuses on developing silicon-based anode materials for lithium-ion batteries. It has also developed an in-house cylindrical battery cell format demonstrating energy density enabled by its silicon anode. Volt14 claims that its technology increases silicon content in anodes while maintaining performance levels and is currently being evaluated by multiple battery cell manufacturers. According to market research, the lithium-ion battery sector is projected to exceed $300 billion by 2034, driven by electric vehicle adoption and energy storage expansion. Blume Ventures, the lead investor in this round, is also one of the early backers of Battery Smart, which is the most funded startup in the space.

Mave Health raises Rs 6 Cr led by All In Capital and iSeed Fund

EntrackrEntrackr · 1y ago
Mave Health raises Rs 6 Cr led by All In Capital and iSeed Fund
Medial

Mave Health, a mental health-tech startup, has raised Rs 6 crore in a pre-seed funding round led by All-In Capital and Utsav Somani’s iSeed Fund with participation from Bharat Founders Fund, Deepinder Goyal (Zomato), Kunal Shah (CRED), Mohit Kumar and Vatsal Singhal (Ultrahuman). The round also saw angel investors like Gaurav Agarwal (TATA 1mg), Nandan Reddy (Swiggy), Rohan Verma (BreatheWellBeing), Nikhil Kant (Even), Harsh Shah (Fynd), Neel Mehta (Studio Carbon), Nitin Mehrotra (Dressfolk), Himanshu Aggarwal (SHL), along with several family offices and digital creators. The funding will support Mave Health in launching Arc, a non-invasive brain stimulation wearable that treats depression, the company said in a press release. Founded in 2023 by Dhawal Jain, Jai Sharma and Aman Kumar, Mave Health aims to build human-centric evidence based programs for mental well-being. The startup’s flagship product Arc improves brain health and treat depression. According to the company, the device is developed in collaboration with a team of top experts, including neuroscientists, psychiatrists, and psychologists from Harvard Medical School, Maastricht University and other leading research institutes. Over the past few months, during the beta phase, more than 1,000 individuals have used Arc and have seen substantial improvements in their depression symptoms. Currently, Mave Health’s flagship wearable, Arc, can be accessed by enrolling in Mave Health’s 12-week long program which also offers unlimited sessions with their experts, including doctors, psychologists, nutritionists, and fitness coaches. Mave Health has also partnered with psychologists, hospitals and private clinics across India to make Arc more accessible.

Download the medial app to read full posts, comements and news.